Company to merge with FLG Merger Sub to Continue Mission of Delivering Next Generation of Accident & Health, Life, and Annuity ProductsCHICAGO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Federal Life Group, Inc. (“Federal Life”), a leading provider, through its affiliates, of insurance and retirement solutions founded in 1899, announced its intent to engage in a short-form merger with its parent. Federal Life’s parent currently owns more than 90% of the common stock of Federal Life (Trading Symbol FLFG). The short-f ...

PHILADELPHIA, PA, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Crane Harbor Acquisition Corp. II (NASDAQ:CRANU) (the “Company”) today announced the upsized pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The Company's units will be listed on the Nasdaq Global Market under the symbol "CRANU" and will begin trading on December 16, 2025. Each unit issued in the offering consists of one Class A ordinary share of the Company and one right to receive one fifteenth (1/15) of a Class ...

Continued profitability expansion with net income of $0.7 million versus net loss of $(1.1) million in Q2 FY2025, and up from net income of $0.4 million in Q1 FY2026Revenue of $11.2 million; USU increases 9% year-over-yearDisciplined cost controls deliver operating income of $1.0 millionPositive Adjusted EBITDA of $2.5 million versus $1.5 million; Adjusted EBITDA margin of 22% versus 14%Fourth consecutive quarter of positive operating cash flow of $0.5 million PHOENIX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Aspe ...

Core Viewpoint - Orezone Gold Corporation has successfully completed its first gold pour from the new 2.5Mtpa hard rock expansion, marking a significant milestone in its operations [1][3]. Group 1: Operational Achievements - The commissioning of the new plant is complete, with mill throughput averaging 78% of nameplate capacity during the first five days of operations [1]. - The construction and commissioning of the Bomboré hard rock expansion were completed on time and on budget within approximately 12 months [2]. Group 2: Future Production Expectations - Commercial production is anticipated to be declared in early Q1-2026, which will represent a major milestone for the company [3]. - Overall gold production at Bomboré is projected to increase by 45% to between 170,000 and 185,000 ounces in 2026 [3][4]. - The company is advancing stage 2 of the hard rock expansion, which is expected to further increase annual production to between 220,000 and 250,000 ounces [4].

FIXYR Initial Activation Processed Over 20,000 Digital Tickets and 200+ Customer Inquiries with 100% Uptime, 100% Satisfaction, and Zero Human InterventionVancouver, BC, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fobi AI Inc. (TSXV:FOBI, Pink:FOBIF) (“Fobi” or the “Company”) is pleased to announce the launch of FIXYR, the Company’s new Agentic AI Customer Service & Technical Support Platform. FIXYR is built on Fobi’s proprietary enterprise large language model infrastructure, using commercially licensed AI models de ...

Fiscal Q2 2026 (which began on Aug 1, 2025 and ended Oct 31, 2025) included a $500M private placement, fueling BNC’s digital assets treasury transformation.World’s Largest BNB Treasury with over 500,000 BNB held, providing unmatched exposure to a leading digital asset ecosystem. LOUISVILLE, CO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: BNC), (“BNC” or the “Company”), today reported financial results for its second fiscal quarter ended October 31, 2025. “This quarter marked the definiti ...

Holders will have until December 30, 2025 to exercise Tranche A Warrants at $1.05 per share, enabling up to $17.9 million in potential gross proceedsBURLINGTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pioneering pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (“T2D”), today announced that it will call all of its outstanding Tranche A Common Stock Purchase Warrants ...

Arbitration Ruling Reaffirms Allogene’s Full Control of Cemacabtagene Ansegedleucel (Cema-Cel)Decision Reconfirms Allogene’s Expanded Sub-License Covering EU and UK Rights with Options for Japan and China, Clearing the Path for Allogene to Acquire Full Global Rights 1H 2026 Interim Futility Analysis from the Pivotal Phase 2 ALPHA3 Trial with Cema-Cel in First-Line (1L) Consolidation Large B-Cell Lymphoma (LBCL) Remains on Track SOUTH SAN FRANCISCO, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeu ...

LITTLETON, Colo., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures and proprietary treatments for sleep related breathing disorders, including obstructive sleep apnea (OSA), today announced that the Company’s CEO Kirk Huntsman and CFO Brad Amman will participate in a fireside chat with Robert Sassoon, senior research analyst of ...

Phoenix, AZ, Dec. 15, 2025 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) reported Hotel Revenue results surpassing $5.8 million once again in the First Three Fiscal Quarters of 2026, (February 1, 2025, to October 31, 2025), with Total Revenue of approximately $5,809,673. Consolidated Net Income before the non-cash expense of depreciation and the non-cash Best Western Rewards Guest Vouchers expense, was approximately break-even at (-48,000), for the 2026 First Fiscal Three Quarters end ...